Progressive Multifocal Leukoencephalopathy - Pipeline Review, H1 2016 Featuring Neurimmune Holding AG & Pomona Ricerca S.R.L - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Progressive Multifocal Leukoencephalopathy - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Progressive Multifocal Leukoencephalopathy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Progressive Multifocal Leukoencephalopathy and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Progressive Multifocal Leukoencephalopathy Overview
  3. Therapeutics Development
  4. Pipeline Products for Progressive Multifocal Leukoencephalopathy - Overview
  5. Pipeline Products for Progressive Multifocal Leukoencephalopathy - Comparative Analysis
  6. Progressive Multifocal Leukoencephalopathy - Therapeutics under Development by Companies
  7. Progressive Multifocal Leukoencephalopathy - Therapeutics under Investigation by Universities/Institutes
  8. Progressive Multifocal Leukoencephalopathy Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Progressive Multifocal Leukoencephalopathy - Products under Development by Companies
  13. Progressive Multifocal Leukoencephalopathy - Products under Investigation by Universities/Institutes
  14. Progressive Multifocal Leukoencephalopathy - Companies Involved in Therapeutics Development
  • Neurimmune Holding AG
  • Pomona Ricerca S.R.L

For more information visit http://www.researchandmarkets.com/research/8l7bnb/progressive

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Central Nervous System Drugs, Infectious Diseases Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Central Nervous System Drugs, Infectious Diseases Drugs